Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $4.78 USD
Change Today -0.01 / -0.21%
Volume 175.2K
As of 5:19 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Maher Albitar M.D.

Chief Medical Officer and Director of Research & Development, Neogenomics Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 4 different industries.

59$1,014,229
As of Fiscal Year 2013

Background*

Dr. Maher Albitar, M.D. has been Chief Medical Officer and Director of Research & Development at NeoGenomics Laboratories, Inc. since January 2012. Dr. Albitar has been Chief Medical Officer and Director of Research & Development of Neogenomics Inc. since January 9, 2012. Dr. Albitar served as a Consultant of Health Discovery Corporation since November 15, 2012 and served as its Chief Medical Officer from May 2010 to April 7, 2011. Dr. Albitar has also served as a consultant ...

Read Full Background

Corporate Headquarters*

12701 Commonwealth Drive
Fort Myers, Florida 33913

United States

Phone: 239-768-0600
Fax: 239-690-4237

Board Members Memberships*

2011-2012
Former Consultant

Education*

MD 1979
Damascus Medical School In Damascus Syria
Post-Doctoral Training
The University of Pennsylvania

Other Affiliations*

Annual Compensation*

Bonus$92,500
Total Annual Compensation$92,500

Stock Options*

All Other Compensation$431,570
Exercisable Options62,500
Unexercisable Options187,500
Total Number of Options250,000

Total Compensation*

Total Annual Cash Compensation$531,710
Total Short Term Compensation$92,500
Other Long Term Compensation$431,570
Total Calculated Compensation$1,014,229
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEO:US $4.78 USD -0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Elazar Rabbani Ph.D.Co-Founder, Chairman, Chief Executive Officer and Secretary
Enzo Biochem Inc.
$555.5K
Raymond C. Kubacki Jr.Chairman, Chief Executive Officer and President
Psychemedics Corp.
$536.9K
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
$800.0K
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$900.3K
Samuel D. Riccitelli Chief Executive Officer, President and Director
Signal Genetics, Inc.
$469.8K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOGENOMICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.